CIK 0001400118 · <br>Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205991472
- Phone
- (650) 561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-23 | Kemble George Executive Chairman | Sale 10b5-1 | −23,625 | $3.17 | $75K | 118,693 |
| 2024-07-19 | Martins Eduardo Bruno Chief Medical Officer | Sale | −8,357 | $3.10 | $26K | 81,213 |
| 2024-07-19 | Rozek Elizabeth General Counsel and CCO | Sale | −10,914 | $3.10 | $34K | 160,506 |
| 2024-07-19 | Kemble George Executive Chairman | Sale | −14,062 | $3.10 | $44K | 142,318 |
| 2024-06-05 | Walbert Timothy P Director | Grant or award · Stock Option (Right to Buy) | +9,279 | 9,279 | ||
| 2024-06-05 | SEIDENBERG BETH C Director | Grant or award · Stock Option (Right to Buy) | +51,459 | 51,459 | ||
| 2024-06-05 | Parsey Merdad Director | Grant or award · Stock Option (Right to Buy) | +51,459 | 51,459 | ||
| 2024-06-05 | Hoelscher Paul W. Director | Grant or award · Stock Option (Right to Buy) | +9,279 | 9,279 | ||
| 2024-06-05 | GRAMMER ELIZABETH A Director | Grant or award · Stock Option (Right to Buy) | +51,459 | 51,459 | ||
| 2024-05-06 | Chauche Thierry Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +587,181 | 587,181 | ||
| 2024-04-01 | Walbert Timothy P Director | Grant or award · Stock Option (Right to Buy) | +73,014 | 73,014 | ||
| 2024-04-01 | Hoelscher Paul W. Director | Grant or award · Stock Option (Right to Buy) | +73,014 | 73,014 | ||
| 2024-03-26 | Happel David President & CEO | Purchase | +12,100 | $5.27 | $64K | 639,200 |
| 2024-01-29 | SANDELL SCOTT D 10% owner | Other disposition | −850,000 | 3,000,275 | ||
| 2024-01-29 | SANDELL SCOTT D 10% owner | Other acquisition | +260,950 | 260,950 | ||
| 2024-01-29 | SANDELL SCOTT D 10% owner | Other disposition | −260,950 | 0 | ||
| 2024-01-29 | SANDELL SCOTT D 10% owner | Other acquisition | +6,997 | 6,997 | ||
| 2024-01-29 | KERINS PATRICK J 10% owner | Other disposition | −850,000 | 3,000,275 | ||
| 2024-01-29 | KERINS PATRICK J 10% owner | Other acquisition | +260,950 | 260,950 | ||
| 2024-01-29 | KERINS PATRICK J 10% owner | Other disposition | −260,950 | 0 |
Page 4 of 10 · 194 trades